what gives, page-24

Bioshares changed their view on avx from buy to lighten when the price hit 29c. It soon raced up to over $1.

Then they put out a buy recommendation (I can't recall at what price) & now they say sell again.

I have wondered if to do the opposite to Bioshare's recommendations. They said strong buy on cce at 42c (now 3c) & strong sell on sla at 22c (now $1.17).

re the dosing. It's interesting that despite great results with the current dosage, the fda want other dosage to be tested. That could easily be seen as a good thing. After all they want an increased dosage to be administered!

wait for the current panic to settle, then buy & hold imho